Tasse Daniel
SEC insider (Form 3/4/5 filer). CIK 0001502785. Director at REGENXBIO Inc. (RGNX) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on May 29, 2026. Located in ROCKVILLE, MD.
Companies Tasse Daniel has filed insider reports for
- REGENXBIO Inc. (RGNX): Director
- DBV Technologies S.A. (DBVT): Director, Officer, CHIEF EXECUTIVE OFFICER
Tasse Daniel
CIK: 0001502785
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 29, 2026RGNX
REGENXBIO Inc.
AwardDirect9.8K shares- - Nov 21, 2025DBVT
DBV Technologies S.A.
AwardDirectEmployee Stock Option (right to buy)
964K shares- - May 30, 2025RGNX
REGENXBIO Inc.
AwardDirect7.8K shares- - Dec 4, 2024DBVT
DBV Technologies S.A.
AwardDirectEmployee Stock Option (right to buy)
813.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 29, 2026 |  RGNX REGENXBIO Inc. | Award | 9,807 | - | $0 | Direct |
| Nov 21, 2025 |  DBVT DBV Technologies S.A. | Award Employee Stock Option (right to buy) | 964,000 | - | - | Direct |
| May 30, 2025 | RGNX REGENXBIO Inc. | Award | 7,768 | - | - | Direct |
| Dec 4, 2024 | DBVT DBV Technologies S.A. | Award Employee Stock Option (right to buy) | 813,200 | - | - | Direct |
1-4 of 4 transactions